Agilent will begin shipping its new HPLC-Chip/MS product in January, the company said Monday at its annual analyst meeting in New York.

The announcement of the launch of the new proteomics product from the company’s Life Sciences and Chemical Analysis business unit served as a backdrop for a narrative of recovery and transformation of the company following an economic downturn that peaked in 2003, Agilent executives told some 80 analysts, media, and investors at the gathering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.